Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHorizon Therapeutics Public Limited Company Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Horizon Therapeutics Public Limited Company Earnings Date And Information
Horizon Therapeutics Public Limited Company last posted its earnings results on Wednesday, November 1st, 2023. The company reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.03. The company had revenue of 944.96 M for the quarter and had revenue of 3.63 B for the year. Horizon Therapeutics Public Limited Company has generated $2 earnings per share over the last year ($2.22 diluted earnings per share) and currently has a price-to-earnings ratio of 51.1. Horizon Therapeutics Public Limited Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 7th, 2023 based on prior year's report dates.
Horizon Therapeutics Public Limited Company Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2023 | Q2 2023 | $1.12 | $0.56 | -0.56 | N/A | $944.96 M |
| 05/03/2023 | Q1 2023 | $1.17 | $0.24 | -0.93 | N/A | $832.06 M |
| 03/01/2023 | Q4 2022 | $1.09 | $0.53 | -0.56 | N/A | $942.03 M |
| 11/02/2022 | Q3 2022 | $1.00 | $0.59 | -0.41 | N/A | $925.36 M |
| 08/03/2022 | Q2 2022 | $1.35 | $0.26 | -1.09 | N/A | $876.41 M |
| 05/04/2022 | Q1 2022 | $1.15 | $0.87 | -0.28 | N/A | $885.25 M |
| 03/01/2022 | Q4 2021 | $1.27 | $0.76 | -0.51 | N/A | $1.01 B |
| 11/03/2021 | Q3 2021 | $1.54 | $1.44 | -0.1 | N/A | $1.04 B |
| 08/04/2021 | Q2 2021 | $0.91 | $0.70 | -0.21 | N/A | $832.55 M |
| 05/05/2021 | Q1 2021 | $0.07 | -$0.55 | -0.62 | N/A | $342.41 M |
| 02/24/2021 | Q4 2020 | $1.05 | $0.86 | -0.19 | N/A | $745.31 M |
| 11/02/2020 | Q3 2020 | $0.97 | $1.38 | 0.41 | N/A | $636.43 M |
| 08/05/2020 | Q2 2020 | $0.40 | -$0.42 | -0.82 | N/A | $462.78 M |
| 05/06/2020 | Q1 2020 | $0.23 | -$0.07 | -0.3 | N/A | $355.91 M |
| 02/26/2020 | Q4 2019 | $0.43 | $3.16 | 2.73 | N/A | $363.55 M |
| 11/06/2019 | Q3 2019 | $0.51 | $0.10 | -0.41 | N/A | $335.47 M |
| 08/07/2019 | Q2 2019 | $0.38 | -$0.03 | -0.41 | N/A | $320.65 M |
| 05/08/2019 | Q1 2019 | $0.10 | -$0.19 | -0.29 | N/A | $280.37 M |
| 02/27/2019 | Q4 2018 | $0.54 | $0.52 | -0.02 | N/A | $355.54 M |
| 11/07/2018 | Q3 2018 | $0.50 | $0.20 | -0.3 | N/A | $325.31 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Horizon Therapeutics Public Limited Company Earnings: FAQ's
Horizon Therapeutics Public Limited Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 7th, 2023 based offlast year's report dates.
In the previous quarter, Horizon Therapeutics Public Limited Company (:HZNP) reported $1.25 earnings per share (EPS) to beat the analysts' consensus estimate of $1.22 by $0.03.
The conference call for Horizon Therapeutics Public Limited Company's latest earnings report can be listened to online.
The conference call transcript for Horizon Therapeutics Public Limited Company's latest earnings report can be read online.
Horizon Therapeutics Public Limited Company (:HZNP) has a recorded annual revenue of $3.63 B.
Horizon Therapeutics Public Limited Company (:HZNP) has a recorded net income of $521.48 M.Horizon Therapeutics Public Limited Company has generated $2.28 earnings per share over the last four quarters.
Horizon Therapeutics Public Limited Company (:HZNP) has a price-to-earnings ratio of 51.1 and price/earnings-to-growth ratio is 0.51.